BECIDIGM
PendingUS US · App #98744959
Owned by
Celgene CorporationApplication date
2024-09-11
Registration date
—
Published date
2025-07-29
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
005006018044046051052
Current owners
Applicants
- Celgene Corporation
Previous owners
- Celgene Corporation
Correspondence
- [Marilyn. F. Kelly] Bristol-Myers Squibb Company
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
0
Security: 0
Renewals
0
Prosecution events
18
Prosecution History
18 events| Date | Event |
|---|---|
| 2026-02-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2026-02-24 | SOU EXTENSION 1 GRANTED |
| 2026-02-24 | SOU EXTENSION 1 FILED |
| 2026-02-24 | SOU TEAS EXTENSION RECEIVED |
| 2025-09-23 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2025-07-29 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2025-07-29 | PUBLISHED FOR OPPOSITION |
| 2025-07-23 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2025-06-24 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2025-06-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2025-06-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2025-06-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2025-03-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2025-03-21 | NON-FINAL ACTION E-MAILED |
| 2025-03-21 | NON-FINAL ACTION WRITTEN |
| 2025-03-21 | ASSIGNED TO EXAMINER |
| 2025-03-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2024-09-11 | NEW APPLICATION ENTERED |